David Hung’s Nuvation to cut 30 jobs, end cancer drug program


The company plans to launch a clinical trial of another drug in combination with a drug developed by its CEO's former company.

Previous State releases proposed health insurance rates for 2023
Next Mimosa House lands second Folsom location